FDA updates warnings for fluoroquinolone antibiotics

July 18, 2018

The FDA recently announced it will update labels for fluoroquinolone antibiotics to increase warnings about the risks of associated adverse mental health effects and serious blood sugar disturbances. The agency is stating that the updates aim to make the warnings more consistent across all labels for fluoroquinolone that are taken orally or injected. This class of antibiotics are commonly used to treat serious bacterial infections. Read the FDA news release for more information. Antibiotics should be used judiciously and appropriately to reduce adverse events and resistance. For more on antibiotic stewardship, contact Meg Kilcup. (Meg Kilcup)


Contact Us

Washington State Hospital Association
999 Third Avenue
Suite 1400
Seattle, WA 98104

Map / Directions

206.281.7211 phone
206.283.6122 fax


Staff List